Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Gufei Capsule is a Traditional Chinese Medicine (TCM) hospital preparation developed by the Affiliated Hospital of Changchun University of Traditional Chinese Medicine for the treatment of osteoporosis. The formulation is based on the 'Bone-Lung Axis' theory in TCM, which suggests a physiological and pathological connection between the lungs and the skeletal system. It is primarily used to tonify the kidney, strengthen the bone, and improve bone mineral density (BMD) in middle-aged and elderly patients. Clinical research, such as trial ChiCTR2100048343, focuses on evaluating its efficacy in reducing the incidence of osteoporotic fractures and optimizing TCM-based clinical evaluation strategies.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Gufei Capsule.